Fonte: British Journal of Haematology. Unidades: FCFRP, FMRP
Assuntos: BIOMARCADORES, INTERFERONS, LEUCEMIA MIELOIDE AGUDA, FARMACOTERAPIA, PROGNÓSTICO
ABNT
CASTRO, Fabíola Attié de et al. Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia. British Journal of Haematology, v. 204, n. 1, p. 206-220, 2023Tradução . . Disponível em: https://doi.org/10.1111/bjh.19107. Acesso em: 08 out. 2025.APA
Castro, F. A. de, Mehdipour, P., Chakravarthy, A., Ettayebi, I., Loo Yau, H., Medina, T. S., et al. (2023). Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia. British Journal of Haematology, 204( 1), 206-220. doi:10.1111/bjh.19107NLM
Castro FA de, Mehdipour P, Chakravarthy A, Ettayebi I, Loo Yau H, Medina TS, Marhon SA, Almeida FC de, Bianco TM, Arruda AG F, Devlin R, Figueiredo‐Pontes LL de, Chahud F, Cacemiro M da C, Minden MD, Gupta V, Carvalho DD de. Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia [Internet]. British Journal of Haematology. 2023 ; 204( 1): 206-220.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/bjh.19107Vancouver
Castro FA de, Mehdipour P, Chakravarthy A, Ettayebi I, Loo Yau H, Medina TS, Marhon SA, Almeida FC de, Bianco TM, Arruda AG F, Devlin R, Figueiredo‐Pontes LL de, Chahud F, Cacemiro M da C, Minden MD, Gupta V, Carvalho DD de. Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia [Internet]. British Journal of Haematology. 2023 ; 204( 1): 206-220.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/bjh.19107